Health & Medical Archives | Page 28 of 242 | Be Korea-savvy

Archive by category Health & Medical

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, March 27, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: 23rd Annual Needham Virtual Healthcare Conference: Zymeworks’ management will participate [...]

Essential Pharma and AcedrA Biopharmaceuticals Sign Distribution Agreement to Commercialize Essential Medicines in the Middle East and North Africa Region

Essential Pharma and AcedrA Biopharmaceuticals Sign Distribution Agreement to Commercialize Essential Medicines in the Middle East and North Africa Region

ZUG, Switzerland and EGHAM, United Kingdom and RIYADH, Saudi Arabia, March 26, 2024 (Korea Bizwire) – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has signed a Distribution Agreement with AcedrA BioPharmaceuticals (“AcedrA”), a [...]

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

RIYADH, Saudi Arabia, March 25, 2024 (Korea Bizwire) – In a ground-breaking development, scientists at King Faisal Specialist Hospital and Research Centre (KFSH&RC) have identified a new species of bacteria, referred to as “Stenotrophomonas Riyadhensis” through the application of whole-genome sequencing (WGS) technology. This discovery signifies a major advancement in understanding how bacteria interact with [...]

Smith+Nephew Teams up with UFC to Be First-ever Preferred Sports Medicine Technology Partner

Smith+Nephew Teams up with UFC to Be First-ever Preferred Sports Medicine Technology Partner

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports. Under the terms of the multi-year partnership, Smith+Nephew will activate its brand through UFC’s [...]

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation

Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation First medical device company to become a corporate champion at the ENTerprise Circle level Mont-Saint-Guibert, Belgium – March 25, 2024, 7:05am CET / 2:05am ET (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a [...]

Philips Convenes the Annual General Meeting of Shareholders 2024

Philips Convenes the Annual General Meeting of Shareholders 2024

March 22, 2024, Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the [...]

Sandoz Opens New Antibiotic Production Facility in Austria, to Significantly Increase Capacity for Life-saving Medicines

Sandoz Opens New Antibiotic Production Facility in Austria, to Significantly Increase Capacity for Life-saving Medicines

EUR 50m investment in Kundl plant extension emphasizes commitment to serve more patients with critical antibiotics, produced entirely in Europe Additional manufacturing area of 3,000m2 means Kundl can now manufacture 240 million packages per year Represents capacity increase of 20% over 2023 and more than doubling from 2021 output levels Automation and innovative technologies allow production [...]

CARBOGEN AMCIS Announces Successful ANVISA Audit of Its Facility in China

CARBOGEN AMCIS Announces Successful ANVISA Audit of Its Facility in China

BUBENDORF, Switzerland, March 19, 2024 (Korea Bizwire) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai. Between 6-10th November 2023, a five-day inspection was undertaken, which concluded successfully with no critical [...]

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain

VALENCIA, Spain, March 19, 2024 (Korea Bizwire) – The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the [...]

SPEVIGO® Approved for Expanded Indications in China and the US

SPEVIGO® Approved for Expanded Indications in China and the US

Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4 In China, SPEVIGO®’s expanded approval adds the reduction of occurrences of GPP in pediatric patients aged 12 and above weighing ≥40 kg, and adults5 The US FDA’s approval expands the use [...]